Slovak patient faces treatment cessation due to insurance coverage denial

Nina Rybárová, a patient with a rare cancer, faces a life-threatening interruption in treatment after her insurer denied coverage for a medication that successfully reduced her tumors. The patient is currently relying on depleting private funds, highlighting systemic gaps in rare disease coverage and pharmaceutical access in Slovakia.